is described, starting from methyl-2 cyclopenten-2 one: These systerns can be used as CD units for building vitamine D3 hydroxylated metabolites (via the previtamine in the case of 2) by reaction with the suitable A ring.
2 and _9
The pionneering work of de Luca' and Kodicek2 has shown that 1S,25-dihydroxycholecalciferol 2 is the active metabolite for physiological calcium translocation, after hydroxylation of vitamin D 1 a t the 25 position in t h e liver and the 1 alpha position in the kidney.
Consequently, this compound has received much attention in the last few years. The second strategy proposed by Lythgoe leads not to cholecalciferol 2 itself but t o the previtamin 3 via the hydroxy sulfone 12 and the tachysterol 2 ( 2 + 10+12+ 13 -1 3 + 3 scheme 2).
-

1S,25-dihydroxycholecalciferol
---Our work on the total synthesis of hydroxylated metabolites of vitamin D3 has been carried out according to the above two strategies proposed by Lythgoe, i.e. either through previtamins such a5 2, or by convergent coupling, using the Wittig reaction, of the ylid 2 and the carbonyl group of a CD unit such as 6. In other words, we set out to prepare 2 either via the previtamin -4, or directly, while keeping in mind the possibility of using as far as possible the same intermediates in both cases. Both these strategies constitute an interesting challenge for a synthetic organic chemist, involving as they do the construction of CD units (6 and 9 ) containing four asymmetric carbon atoms and a functionality a t position 8 (either a methylenesulfone as in -9, or a carbonyl as in 2 1, and A-ring units containing an aldehyde 2 or phosphine 8 function.
This lecture will only be concerned with our work directed towards the synthesis of the CD-ring components 5, 6, and 2. One of the difficulties which must be overcome in the synthesis of these units is the stereochemical control of their chiral centers, and in particular of the chiral center on the flexible side chain (position 20). It so happens that, some years ago, we developed a method which solves this problem, since it fixes the stereochemistry of an asymmetric center on a flexible side chain adjacent to a five6 or six7 membered ring. This is made possible by the stereochemical control of the hydrolysis of the bicyclic enamines (e.g., 2) formed from the cycloaddition between the ynamines 2 and cycloalkenones (scheme 3).
Used as a key step to fix the stereochemistry of the asymetric centers in the side chain of the CD units J, 2, and 2, this method consists in the hydrolysis of the adducts -15 formed by cycloaddition of the ynamines 2 with, 2-methylcyclopentenone, the five-membered ring of which will eventually constitute the D-ring of the CD unit. And indeed, using our method, the thermodynamically controlled hydrolysis of the bicyclic enamine 2 afforded the keto-acid -16, which was then readily converted into the desired cyclopentanone Is, after resolution which leads to the pure enantiomer . The carboxyl group was then introduced12 t o form the keto-acid 2 (R=H); this key intermediate is a precursor of both the desired CD units and 2. The carboxyl group plays a dual role. On the one hand it controls the stereochemistry of the catalytic reduction of the 12-13 double bond and hence of the fourth asymmetric center (position 14) of the hydrindanone 24 ; in the absence of the carboxyl group, the CD ring junction would be & s rather than -trans. On the other hand, the carboxyl group regioselectivity attached t o carbon atom 8, will be used t o build, at will, the functionnalities of CD units 2, j and also _9 which, are different, but in all cases substituents at position 8.
The catalytic reduction (H2, Pt) of 2 (R=H) leads in excellent yields t o keto-acid 2 (R=H) as a single isomer (as shown by 13C, 'H, NMR of the corresponding ester 2 [R=Me] ). This catalytic reduction step, thus controlled the fourth asymetric center (position 14).
Sulfone _9 which was prepared from the keto-ester 24 (R=Me) can lead t o the hydroxy-previtamine _4 by reaction with 2, whereas the hydrindanones 5 and _9 which were prepared from keto-acid 2_4 (R=H) can lead directly t o dihydroxy vitamine 4 via reaction with _8.
The transformation of keto-ester 2 (R=Me) into the sulfone 2 was performed with no particular problems via ethylenic ester 3. This ester 2 was reduced into the corresponding alcohol -27 (R=OH) precursor of chloro compound 2 (R=Cl) which was displaced by sodium sulfinate t o give the sulfone 2 (scheme 5).
The ethylenic ester 26 was prepared by elimination of the benzoate of hydroxyester 25 (using lithium isopropylamid, 1 eq., -7 8 O , 25OC) obtained by reduction (L selectride) of keto-ester 2 (R=Me).
It is, on the other hand, the keto-acid 2 (R=H) and not its methyl ester 2 (R=Me) which was used t o synthetize the hydrindanones 2 and $. This transformation was performed according t o the following steps (scheme 6): first, a decarboxylativ Mannich reaction leads from 2 (R=H) t o ketone 2 which is then reduced (Dibal) t o the alcohol 2. The methylene of this alcohol 2, later becomes the crucial carbonyl of hydrindanones 2 and $ by ozonolysis ( g j s ) followed by reductiv elimination (Ca in NH3) of benzoate 30. This benzoate led t o the desired hydrindanones 2 and 5 in the last step : ( 3 0 4 5 and 3 0 + 6 ) .
----
Scheme 6
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